Full Name | Amin Shazly |
---|---|
Gender | Male |
Speciality | Anesthesiology |
Experience | 12 Years |
Location | 1 Cooper Plz, Camden, New Jersey |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1780024117 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | 207L00000X (New Jersey) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
St Joseph Medical Center | Reading, PA | Hospital |
Crozer Chester Medical Center | Upland, PA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
St Joseph Medical Group | 3779688650 | 171 |
Associates In Anesthesia, Inc. | 9335052034 | 56 |
News Archive
Gilead Sciences, Inc. today provided an update on the company's previously announced $5.0 billion stock repurchase program authorized by Gilead's Board of Directors in May 2010.
Researchers often get frustrated when doctors fail to adopt treatment guidelines backed by the best evidence-based research.
When stroke strikes, choking off blood supply to the brain, every minute counts: Nearly 2 million neurons die each minute a stroke is left untreated, making it a race to recognize symptoms so that lifesaving "clot-busting" drugs can be administered.
Two medications approved as treatment for drug-resistant chronic myeloid leukemia continue to provide patients with quicker, better responses as a first treatment than the existing front-line drug, researchers at The University of Texas M. D. Anderson Cancer Center reported at the 51st Annual Meeting of the American Society of Hematology.
"The Global Fund to Fight AIDS, Tuberculosis and Malaria announced on Monday that it will withhold $95 million from the $270 million in grants it had planned to give China" after "months of discussion between the charity and Chinese officials," China Daily reports.
› Verified 4 days ago
Entity Name | Associates In Anesthesia, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1942281191 PECOS PAC ID: 9335052034 Enrollment ID: O20031124000710 |
News Archive
Gilead Sciences, Inc. today provided an update on the company's previously announced $5.0 billion stock repurchase program authorized by Gilead's Board of Directors in May 2010.
Researchers often get frustrated when doctors fail to adopt treatment guidelines backed by the best evidence-based research.
When stroke strikes, choking off blood supply to the brain, every minute counts: Nearly 2 million neurons die each minute a stroke is left untreated, making it a race to recognize symptoms so that lifesaving "clot-busting" drugs can be administered.
Two medications approved as treatment for drug-resistant chronic myeloid leukemia continue to provide patients with quicker, better responses as a first treatment than the existing front-line drug, researchers at The University of Texas M. D. Anderson Cancer Center reported at the 51st Annual Meeting of the American Society of Hematology.
"The Global Fund to Fight AIDS, Tuberculosis and Malaria announced on Monday that it will withhold $95 million from the $270 million in grants it had planned to give China" after "months of discussion between the charity and Chinese officials," China Daily reports.
› Verified 4 days ago
Entity Name | St Joseph Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1184754657 PECOS PAC ID: 3779688650 Enrollment ID: O20070421000011 |
News Archive
Gilead Sciences, Inc. today provided an update on the company's previously announced $5.0 billion stock repurchase program authorized by Gilead's Board of Directors in May 2010.
Researchers often get frustrated when doctors fail to adopt treatment guidelines backed by the best evidence-based research.
When stroke strikes, choking off blood supply to the brain, every minute counts: Nearly 2 million neurons die each minute a stroke is left untreated, making it a race to recognize symptoms so that lifesaving "clot-busting" drugs can be administered.
Two medications approved as treatment for drug-resistant chronic myeloid leukemia continue to provide patients with quicker, better responses as a first treatment than the existing front-line drug, researchers at The University of Texas M. D. Anderson Cancer Center reported at the 51st Annual Meeting of the American Society of Hematology.
"The Global Fund to Fight AIDS, Tuberculosis and Malaria announced on Monday that it will withhold $95 million from the $270 million in grants it had planned to give China" after "months of discussion between the charity and Chinese officials," China Daily reports.
› Verified 4 days ago
Entity Name | Northstar Anesthesia Of Pennsylvania Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1700218989 PECOS PAC ID: 5092941161 Enrollment ID: O20131119001358 |
News Archive
Gilead Sciences, Inc. today provided an update on the company's previously announced $5.0 billion stock repurchase program authorized by Gilead's Board of Directors in May 2010.
Researchers often get frustrated when doctors fail to adopt treatment guidelines backed by the best evidence-based research.
When stroke strikes, choking off blood supply to the brain, every minute counts: Nearly 2 million neurons die each minute a stroke is left untreated, making it a race to recognize symptoms so that lifesaving "clot-busting" drugs can be administered.
Two medications approved as treatment for drug-resistant chronic myeloid leukemia continue to provide patients with quicker, better responses as a first treatment than the existing front-line drug, researchers at The University of Texas M. D. Anderson Cancer Center reported at the 51st Annual Meeting of the American Society of Hematology.
"The Global Fund to Fight AIDS, Tuberculosis and Malaria announced on Monday that it will withhold $95 million from the $270 million in grants it had planned to give China" after "months of discussion between the charity and Chinese officials," China Daily reports.
› Verified 4 days ago
Entity Name | Xenon Anesthesia Of Pennsylvania, Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1780114173 PECOS PAC ID: 0547533895 Enrollment ID: O20170907002283 |
News Archive
Gilead Sciences, Inc. today provided an update on the company's previously announced $5.0 billion stock repurchase program authorized by Gilead's Board of Directors in May 2010.
Researchers often get frustrated when doctors fail to adopt treatment guidelines backed by the best evidence-based research.
When stroke strikes, choking off blood supply to the brain, every minute counts: Nearly 2 million neurons die each minute a stroke is left untreated, making it a race to recognize symptoms so that lifesaving "clot-busting" drugs can be administered.
Two medications approved as treatment for drug-resistant chronic myeloid leukemia continue to provide patients with quicker, better responses as a first treatment than the existing front-line drug, researchers at The University of Texas M. D. Anderson Cancer Center reported at the 51st Annual Meeting of the American Society of Hematology.
"The Global Fund to Fight AIDS, Tuberculosis and Malaria announced on Monday that it will withhold $95 million from the $270 million in grants it had planned to give China" after "months of discussion between the charity and Chinese officials," China Daily reports.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Amin Shazly, 230 N 21st St, Apt. 109, Philadelphia, PA 19103-1095 Ph: () - | Amin Shazly, 1 Cooper Plz, Camden, NJ 08103-1461 Ph: (856) 968-7330 |
News Archive
Gilead Sciences, Inc. today provided an update on the company's previously announced $5.0 billion stock repurchase program authorized by Gilead's Board of Directors in May 2010.
Researchers often get frustrated when doctors fail to adopt treatment guidelines backed by the best evidence-based research.
When stroke strikes, choking off blood supply to the brain, every minute counts: Nearly 2 million neurons die each minute a stroke is left untreated, making it a race to recognize symptoms so that lifesaving "clot-busting" drugs can be administered.
Two medications approved as treatment for drug-resistant chronic myeloid leukemia continue to provide patients with quicker, better responses as a first treatment than the existing front-line drug, researchers at The University of Texas M. D. Anderson Cancer Center reported at the 51st Annual Meeting of the American Society of Hematology.
"The Global Fund to Fight AIDS, Tuberculosis and Malaria announced on Monday that it will withhold $95 million from the $270 million in grants it had planned to give China" after "months of discussion between the charity and Chinese officials," China Daily reports.
› Verified 4 days ago
Dr. Maria Cassotis, D.O Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 484-832-7271 | |
James M Armstrong, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: Our Lady Of Lourdes Medical Center, 1600 Haddon Avenue, Camden, NJ 08103 Phone: 856-757-3836 | |
Julie Mathew, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz Dept Of, Camden, NJ 08103 Phone: 856-342-2425 | |
Dr. Dejan Vuckovic, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 856-342-2425 | |
Khalid A Hanafy, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 856-546-8525 | |
Dennis Mcfadden, CRNA Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Cooper Anethesia Associates, Camden, NJ 08103 Phone: 856-342-2425 Fax: 856-968-8239 | |
Dr. Kelly Ann Bolkus, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 856-342-2425 |